Subsequently, sMICA and sMICB inhibit the function of NKG2D and damage the cytotoxic effect of NK cells, causing tumor cells to be unable to be effectively killed by NK cells and CD8+ T cells, mediating tumor immune escape and disease progression. The gene discussed is KLRK1; the disease is neoplasm.